We are monitoring the impact of COVID-19 on MEA Epigenetics Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1886
Pages: 145

MEA Epigenetics Market Size (2022 to 2027)

The Epigenetics Market size in the Middle East & Africa is estimated to reach USD 131.09 million by 2027 from a market value of USD 79.57 million in 2022, registering a CAGR of 10.5% during the forecast period.

The increasing prevalence of chronic diseases such as cancer and other targeted diseases drives the MEA Epigenetics market. Also, the growing geriatric population, rising awareness about Epigenetics are expected to augment the market growth. Other growth-inducing factors include creating DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, and ligases and introducing sensitive and selective testing and instruments.

In addition, increasing funding for epigenetics research and a growing number of applications of epigenetics in non-oncology diseases boost the market growth during the forecast period.  On the other hand, the growth opportunities in developing countries such South Africa, UAE, and Saudi Arabia are estimated to provide lucrative growth opportunities to the market players. However, growing partnerships between academic, pharmaceutical, and biotechnology companies expand the MEA Epigenetics market. 

Moreover, the unexpected outbreak of coronavirus disease (COVID-19), on the other hand, presents market participants with growth opportunities. Various research institutes, for example, are conducting advanced epigenetic testing to study the virus's influence on the human genome and creating methods for early detection, risk assessments, and personalized therapies. Further, the region's major players are conducting R&D activities in the biotechnology field due to the growing funding by the government and private organizations.

The main factors limiting the epigenetics market growth are the scarcity of qualified people at diagnostic centers who can use the systems and the high costs of the equipment and treatment choices. In addition, the absence of government payment systems, particularly in emerging countries, and a lack of awareness of various epigenetic techniques are expected to hinder the market growth. 

This research report on the MEA Epigenetics Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Enzymes
  • Instruments & Consumable
  • KITS
  • Reagents

By Research Area: 

  • Developmental Biology
  • Oncology
  • Drug Delivery

By Enzymes: 

  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • RNA-Modifying Enzymes

By Instruments & Consumables: 

  • Mass Spectrometers
  • Next-Generation Sequencers
  • qPCR
  • Sonicators

By KITS:

  • Bisulfite Conversion KITS
  • Chip-Sequence KITS
  • RNA Sequencing KITS
  • Whole-Genome Amplification KITS
  • 5-HMC and 5-MC Analysis KITS

By Reagents:

  • Antibodies
  • Buffers
  • Histones
  • Magnetic Beads
  • Primers

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA is projected to register a considerable share in the Epigenetics market during the forecast period. Government initiatives for encouraging the development of biopharmaceutical and biotechnology companies in the MEA are propelling market growth. In recent years, many companies researching techniques to detect methylation-induced DNA alteration have remained relatively constant. The developing countries such as South Africa, Saudi Arabia, and UAE significantly contribute to the MEA regional market growth.

South America is anticipated to be the major country to have a significant share in the Epigenetic market. The market growth is attributed to the improving healthcare sector, growing adoption of applications in non-oncology diseases, and increasing healthcare expenditure. Moreover, a growing partnership between academic, biotechnology, and pharmaceutical companies to provide lucrative growth opportunities for the market players is expanding the market growth.

On the other hand, Saudi Arabia and UAE are projected to witness a promising share during the forecast period. The proliferation of cancer, the growing geriatric population, and improving technological advancement in the healthcare sector. Also, advancing healthcare infrastructure, favorable government funding, and rising healthcare expenditure fuel market growth.

KEY MARKET PLAYERS:

Companies such as Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc., and Zymo Research Corporation are playing a leading role in the MEA Epigenetics Market.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Enzymes                                  

                                                5.1.2.1 DNA-Modifying Enzymes                              

                                                5.1.2.2 Protein-Modifying Enzymes                        

                                                5.1.2.3 RNA-Modifying Enzymes                              

                                5.1.3 Instruments & Consumables                                           

                                                5.1.3.1 Mass Spectrometers                       

                                                5.1.3.2 Next-Generation Sequencers                     

                                                5.1.3.3 QPCR                     

                                                5.1.3.4 Sonicators                            

                                                5.1.3.5 Others                   

                                5.1.4 KITS                                            

                                                5.1.4.1 Bisulfite Conversion KITS                               

                                                5.1.4.2 Chip-Sequence KITS                        

                                                5.1.4.3 RNA Sequencing KITS                     

                                                5.1.4.4 Whole-Genome Amplification KITS                          

                                                5.1.4.5 5-HMC and 5-MC Analysis KITS                   

                                                5.1.4.6 Others                   

                                5.1.5 Reagents                                 

                                                5.1.5.1 Antibodies                           

                                                5.1.5.2  buffers                 

                                                5.1.5.3 Histones                               

                                                5.1.5.4 Magnetic Beads                

                                                5.1.5.5 Primers                 

                                                5.1.5.6 Others                   

                                5.1.6  Y-o-Y Growth Analysis, By Product                                              

                                5.1.7 Market Attractiveness Analysis, By Product                                             

                                5.1.8  Market Share Analysis, By Product                                              

                5.2 Research Area                                                           

                                5.2.1 Introduction                                           

                                5.2.2 Developmental Biology                                     

                                5.2.3 Oncology                                 

                                5.2.4 Drug Delivery                                         

                                5.2.5 Y-o-Y Growth Analysis, By Research Area                                  

                                5.2.6 Market Attractiveness Analysis, By Research Area                                

                                5.2.7 Market Share Analysis, By Research Area                                  

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Research Area                             

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Research Area                             

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Research Area                             

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Abcam plc.                                                  

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Illumina, Inc.                                                              

                8.3 QIAGEN N.V.                                                             

                8.4 Merck & Co.                                                               

                8.5 New England Biolabs, Inc.                                                    

                8.6 Zymo Research Corporation                                                

                8.7 Sigma-Aldrich Corporation                                                   

                8.8 Thermo Fisher Scientific, Inc.                                                              

                8.9 Active Motif                                                               

                8.10 Diagenode, Inc.                                                      

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  1. Middle East & Africa Epigenetics Market By Product, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Enzymes Market By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Instruments & Consumables Market By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa KITS Market By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Reagents Market By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Epigenetics Market By Research area, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Developmental Biology Market By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Oncology Market By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Drug Delivery Market By Region, From 2022 - 2027 (USD Million)
  10. Middle East Epigenetics Market By Product, From 2022 - 2027 (USD Million)
  11. Middle East Epigenetics Market By Research area, From 2022 - 2027 (USD Million)
  12. Africa Epigenetics Market By Product, From 2022 - 2027 (USD Million)
  13. Africa Epigenetics Market By Research area, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Epigenetics Market By Enzymes, From 2022 - 2027 (USD Million)
  15. Middle East & Africa DNA-Modifying Enzymes Market By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Protein-Modifying Enzymes Market By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa RNA-Modifying Enzymes Market By Region, From 2022 - 2027 (USD Million)
  18. Middle East Epigenetics Market By Enzymes, From 2022 - 2027 (USD Million)
  19. Africa Epigenetics Market By Enzymes, From 2022 - 2027 (USD Million)
  20. Middle East & Africa Epigenetics Market By Instruments & Consumables , From 2022 - 2027 (USD Million)
  21. Middle East & Africa Mass Spectrometers Market By Region, From 2022 - 2027 (USD Million)
  22. Middle East & Africa Next-Generation Sequencers Market By Region, From 2022 - 2027 (USD Million)
  23. Middle East & Africa QPCR Market By Region, From 2022 - 2027 (USD Million)
  24. Middle East & Africa Sonicators Market By Region, From 2022 - 2027 (USD Million)
  25. Middle East & Africa Others Market By Region, From 2022 - 2027 (USD Million)
  26. Middle East Epigenetics Market By Instruments & Consumables , From 2022 - 2027 (USD Million)
  27. Africa Epigenetics Market By Instruments & Consumables , From 2022 - 2027 (USD Million)
  28. Middle East & Africa Epigenetics Market By KITS, From 2022 - 2027 (USD Million)
  29. Middle East & Africa Bisulfite Conversion KITS Market By Region, From 2022 - 2027 (USD Million)
  30. Middle East & Africa Chip-Sequence KITS Market By Region, From 2022 - 2027 (USD Million)
  31. Middle East & Africa RNA Sequencing KITS Market By Region, From 2022 - 2027 (USD Million)
  32. Middle East & Africa Whole-Genome Amplification KITS Market By Region, From 2022 - 2027 (USD Million)
  33. Middle East & Africa 5-HMC and 5-MC Analysis KITS Market By Region, From 2022 - 2027 (USD Million)
  34. Middle East & Africa Others Market By Region, From 2022 - 2027 (USD Million)
  35. Middle East Epigenetics Market By KITS, From 2022 - 2027 (USD Million)
  36. Africa Epigenetics Market By KITS, From 2022 - 2027 (USD Million)
  37. Middle East & Africa Epigenetics Market By Reagent, From 2022 - 2027 (USD Million)
  38. Middle East & Africa Antibodies Market By Region, From 2022 - 2027 (USD Million)
  39. Middle East & Africa buffers Market By Region, From 2022 - 2027 (USD Million)
  40. Middle East & Africa Histones Market By Region, From 2022 - 2027 (USD Million)
  41. Middle East & Africa Magnetic Beads Market By Region, From 2022 - 2027 (USD Million)
  42. Middle East & Africa Primers  Market By Region, From 2022 - 2027 (USD Million)
  43. Middle East & Africa Others Market By Region, From 2022 - 2027 (USD Million)
  44. Middle East Epigenetics Market By Reagent, From 2022 - 2027 (USD Million)
  45. Africa Epigenetics Market By Reagent, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample